Alzheimers

The illustration shows an old man sitting next to an animated human brain.— PixabayA recent study published in Acta Neuropathologica has found that eyes can be a good source to determine if a person is living with Alzheimer's or any…

Changes in the brain caused by Alzheimer's disease are associated with shortening of the telomeres -- the protective caps on the ends of chromosomes that shorten as cells age -- according to a new study led by Anya Topiwala of Oxford…

A majority of people living with Alzheimer’s disease are women, and in wake of the startling stat, some Canadians are hoping to help mitigate their chances with an app that helps promote healthy brain habits. Kathy Kelaidis, a busy…

New Delhi: Football players are 1.5 times more likely to develop neurodegenerative disease than others in their age group, says an observational study published in the medical journal Lancet. According to the Swedish study that covered…

Researchers from Drexel University have uncovered a novel regulatory mechanism in the brain that is essential for making the right kinds of proteins that promote healthy brain function, and its malfunctioning may be an early contributor of…

Anyone who has watched Casualty or 24 Hours In A&E, or read a book about life as an emergency doctor, would expect my job — as an A&E consultant — to be filled with dramatic life and death situations; stabbings, car accidents and…

The Veterans' Health Administration will cover Eisai and Biogen's Alzheimer's treatment Leqembi for some patients, the companies announced on Monday.In a statement, Eisai said veterans in the early stages of the disease who meet VHA…

Sometimes the best things in life come by chance, when we happen to be in the right place at the right time. Now, researchers from Japan have found a way to ensure that new medications are delivered to the right place in the body and at the…

People who eat diets rich in green leafy vegetables as well as other vegetables, fruits, whole grains, olive oil, beans, nuts and fish may have fewer amyloid plaques and tau tangles in their brain -- signs of Alzheimer's disease -- than…

Eli Lilly on Wednesday said it will halt development of its Alzheimer's treatment candidate solanezumab after the antibody failed to slow disease progression.Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who are…